GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2f1
|
ENSMUSG00000069171.15 | nuclear receptor subfamily 2, group F, member 1 |
Nr4a1
|
ENSMUSG00000023034.8 | nuclear receptor subfamily 4, group A, member 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr2f1 | mm39_v1_chr13_-_78344492_78344561 | -0.18 | 3.1e-01 | Click! |
Nr4a1 | mm39_v1_chr15_+_101152078_101152211 | -0.02 | 9.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_46146558 | 59.00 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr9_-_46146928 | 43.96 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr7_-_140856642 | 35.00 |
ENSMUST00000080654.7
ENSMUST00000167263.9 |
Cdhr5
|
cadherin-related family member 5 |
chr4_+_115375461 | 32.41 |
ENSMUST00000058785.10
ENSMUST00000094886.4 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr7_-_105249308 | 24.30 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr2_+_172994841 | 23.39 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr10_+_128030315 | 19.35 |
ENSMUST00000044776.13
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr3_-_81883509 | 17.79 |
ENSMUST00000029645.14
ENSMUST00000193879.2 |
Tdo2
|
tryptophan 2,3-dioxygenase |
chr19_-_43512929 | 14.85 |
ENSMUST00000026196.14
|
Got1
|
glutamic-oxaloacetic transaminase 1, soluble |
chr6_+_90527762 | 14.08 |
ENSMUST00000130418.8
ENSMUST00000032175.11 ENSMUST00000203111.2 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr10_+_128030500 | 13.25 |
ENSMUST00000123291.2
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr4_+_134123631 | 12.92 |
ENSMUST00000105869.9
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr11_+_115353290 | 12.70 |
ENSMUST00000106532.4
ENSMUST00000092445.12 ENSMUST00000153466.2 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr2_+_71811526 | 12.55 |
ENSMUST00000090826.12
ENSMUST00000102698.10 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr4_-_62005498 | 12.44 |
ENSMUST00000107488.4
ENSMUST00000107472.8 ENSMUST00000084531.11 |
Mup3
|
major urinary protein 3 |
chr1_+_88093726 | 12.18 |
ENSMUST00000097659.5
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr11_-_116089595 | 12.06 |
ENSMUST00000072948.11
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr4_-_107164347 | 12.03 |
ENSMUST00000082426.11
|
Dio1
|
deiodinase, iodothyronine, type I |
chr4_-_107164315 | 11.19 |
ENSMUST00000126291.2
ENSMUST00000106748.2 ENSMUST00000129138.2 |
Dio1
|
deiodinase, iodothyronine, type I |
chr4_+_140688514 | 11.08 |
ENSMUST00000010007.9
|
Sdhb
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
chr7_+_51537645 | 10.90 |
ENSMUST00000208711.2
|
Gas2
|
growth arrest specific 2 |
chr11_+_74540284 | 10.35 |
ENSMUST00000117818.2
ENSMUST00000092915.12 |
Cluh
|
clustered mitochondria (cluA/CLU1) homolog |
chr5_-_123320767 | 10.30 |
ENSMUST00000154713.8
ENSMUST00000031398.14 |
Hpd
|
4-hydroxyphenylpyruvic acid dioxygenase |
chr15_-_96947963 | 10.24 |
ENSMUST00000230907.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr11_+_75400889 | 10.09 |
ENSMUST00000042972.7
|
Rilp
|
Rab interacting lysosomal protein |
chr4_-_60457902 | 10.00 |
ENSMUST00000084548.11
ENSMUST00000103012.10 ENSMUST00000107499.4 |
Mup1
|
major urinary protein 1 |
chr17_-_46749370 | 9.99 |
ENSMUST00000087012.7
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr17_-_56424265 | 9.79 |
ENSMUST00000113072.3
|
Plin5
|
perilipin 5 |
chr18_-_35760260 | 9.69 |
ENSMUST00000025212.8
|
Slc23a1
|
solute carrier family 23 (nucleobase transporters), member 1 |
chr17_-_56424577 | 9.36 |
ENSMUST00000019808.12
|
Plin5
|
perilipin 5 |
chrX_-_37545311 | 9.20 |
ENSMUST00000074913.12
ENSMUST00000016678.14 ENSMUST00000061755.9 |
Lamp2
|
lysosomal-associated membrane protein 2 |
chr3_-_137837117 | 9.18 |
ENSMUST00000029805.13
|
Mttp
|
microsomal triglyceride transfer protein |
chr3_-_20329823 | 8.98 |
ENSMUST00000011607.6
|
Cpb1
|
carboxypeptidase B1 (tissue) |
chr2_+_58645189 | 8.91 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr9_+_46179899 | 8.83 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr1_-_139708906 | 8.65 |
ENSMUST00000111986.8
ENSMUST00000027612.11 ENSMUST00000111989.9 |
Cfhr4
|
complement factor H-related 4 |
chr9_+_46151994 | 8.57 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr1_+_74324089 | 8.47 |
ENSMUST00000113805.8
ENSMUST00000027370.13 ENSMUST00000087226.11 |
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr4_-_60777462 | 8.47 |
ENSMUST00000211875.2
|
Mup22
|
major urinary protein 22 |
chr10_-_78300802 | 8.45 |
ENSMUST00000041616.15
|
Pdxk
|
pyridoxal (pyridoxine, vitamin B6) kinase |
chr4_-_60697274 | 8.40 |
ENSMUST00000117932.2
|
Mup12
|
major urinary protein 12 |
chr19_+_46120327 | 8.38 |
ENSMUST00000043739.6
ENSMUST00000237098.2 |
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr3_+_130411097 | 8.35 |
ENSMUST00000166187.8
ENSMUST00000072271.13 |
Etnppl
|
ethanolamine phosphate phospholyase |
chr9_-_107546195 | 8.35 |
ENSMUST00000192990.6
|
Slc38a3
|
solute carrier family 38, member 3 |
chr7_-_30755007 | 8.35 |
ENSMUST00000206474.2
ENSMUST00000205807.2 ENSMUST00000039909.13 ENSMUST00000206305.2 ENSMUST00000205439.2 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr8_+_70525546 | 8.27 |
ENSMUST00000110160.9
ENSMUST00000049197.6 |
Tm6sf2
|
transmembrane 6 superfamily member 2 |
chr1_-_139786421 | 8.18 |
ENSMUST00000194186.6
ENSMUST00000094489.5 ENSMUST00000239380.2 |
Cfhr2
|
complement factor H-related 2 |
chr7_-_30754223 | 8.05 |
ENSMUST00000206012.2
ENSMUST00000108110.5 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr1_-_139487951 | 8.01 |
ENSMUST00000023965.8
|
Cfhr1
|
complement factor H-related 1 |
chr13_-_41981812 | 7.98 |
ENSMUST00000223337.2
ENSMUST00000221691.2 |
Adtrp
|
androgen dependent TFPI regulating protein |
chr9_-_65330231 | 7.96 |
ENSMUST00000065894.7
|
Slc51b
|
solute carrier family 51, beta subunit |
chr9_-_107546166 | 7.96 |
ENSMUST00000177567.8
|
Slc38a3
|
solute carrier family 38, member 3 |
chr6_+_42222841 | 7.96 |
ENSMUST00000031897.8
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr11_+_69945157 | 7.77 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr2_-_91466739 | 7.72 |
ENSMUST00000111335.2
ENSMUST00000028681.15 |
F2
|
coagulation factor II |
chr6_-_113508536 | 7.68 |
ENSMUST00000032425.7
|
Emc3
|
ER membrane protein complex subunit 3 |
chr7_-_30754193 | 7.60 |
ENSMUST00000205778.2
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr11_-_116089866 | 7.59 |
ENSMUST00000066587.12
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr1_-_140111138 | 7.57 |
ENSMUST00000111976.9
ENSMUST00000066859.13 |
Cfh
|
complement component factor h |
chr4_-_60222580 | 7.44 |
ENSMUST00000095058.5
ENSMUST00000163931.8 |
Mup8
|
major urinary protein 8 |
chr2_+_58644922 | 7.42 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chr7_+_83281167 | 7.30 |
ENSMUST00000075418.15
|
Stard5
|
StAR-related lipid transfer (START) domain containing 5 |
chr1_-_140111018 | 7.29 |
ENSMUST00000192880.6
ENSMUST00000111977.8 |
Cfh
|
complement component factor h |
chr4_+_133280680 | 7.20 |
ENSMUST00000042706.3
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr6_+_138117519 | 7.20 |
ENSMUST00000120939.8
ENSMUST00000204628.3 ENSMUST00000140932.2 ENSMUST00000120302.8 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr9_+_107957621 | 7.16 |
ENSMUST00000035211.14
|
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr5_-_87288177 | 7.11 |
ENSMUST00000067790.7
|
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr9_+_107957640 | 7.00 |
ENSMUST00000162886.2
|
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chrX_+_59044796 | 6.89 |
ENSMUST00000033477.5
|
F9
|
coagulation factor IX |
chr13_-_74498320 | 6.82 |
ENSMUST00000221594.2
ENSMUST00000022062.8 |
Sdha
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
chr17_-_35081456 | 6.81 |
ENSMUST00000025229.11
ENSMUST00000176203.9 ENSMUST00000128767.8 |
Cfb
|
complement factor B |
chr14_-_30637344 | 6.77 |
ENSMUST00000226547.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr9_-_21900724 | 6.71 |
ENSMUST00000045726.8
|
Rgl3
|
ral guanine nucleotide dissociation stimulator-like 3 |
chr15_+_76579885 | 6.68 |
ENSMUST00000231028.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr11_-_53321606 | 6.62 |
ENSMUST00000061326.5
ENSMUST00000109021.4 |
Uqcrq
|
ubiquinol-cytochrome c reductase, complex III subunit VII |
chr14_+_79086665 | 6.61 |
ENSMUST00000227255.2
|
Vwa8
|
von Willebrand factor A domain containing 8 |
chr5_+_114284585 | 6.55 |
ENSMUST00000102582.8
|
Acacb
|
acetyl-Coenzyme A carboxylase beta |
chr7_+_140500808 | 6.54 |
ENSMUST00000106045.8
ENSMUST00000183845.8 |
Nlrp6
|
NLR family, pyrin domain containing 6 |
chr9_-_70841881 | 6.46 |
ENSMUST00000214995.2
|
Lipc
|
lipase, hepatic |
chr3_+_32791139 | 6.44 |
ENSMUST00000127477.8
ENSMUST00000121778.8 ENSMUST00000154257.8 |
Ndufb5
|
NADH:ubiquinone oxidoreductase subunit B5 |
chr14_-_20844074 | 6.38 |
ENSMUST00000080440.14
ENSMUST00000100837.11 ENSMUST00000071816.7 |
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma |
chr4_+_117109148 | 6.35 |
ENSMUST00000062824.12
|
Tmem53
|
transmembrane protein 53 |
chr3_+_130411294 | 6.33 |
ENSMUST00000163620.8
|
Etnppl
|
ethanolamine phosphate phospholyase |
chr15_+_7159038 | 6.33 |
ENSMUST00000067190.12
ENSMUST00000164529.9 |
Lifr
|
LIF receptor alpha |
chr7_-_30754240 | 6.32 |
ENSMUST00000206860.2
ENSMUST00000071697.11 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr4_+_117109204 | 6.29 |
ENSMUST00000125943.8
ENSMUST00000106434.8 |
Tmem53
|
transmembrane protein 53 |
chr1_-_192946359 | 6.28 |
ENSMUST00000161737.8
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr8_+_95564949 | 6.25 |
ENSMUST00000034234.15
ENSMUST00000159871.4 |
Coq9
|
coenzyme Q9 |
chr17_-_35081129 | 6.22 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr4_-_6275629 | 6.22 |
ENSMUST00000029905.2
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr6_+_145156860 | 6.18 |
ENSMUST00000111725.8
ENSMUST00000111726.10 ENSMUST00000039729.5 ENSMUST00000111723.8 ENSMUST00000111724.8 ENSMUST00000111721.2 ENSMUST00000111719.2 |
Etfrf1
|
electron transfer flavoprotein regulatory factor 1 |
chr1_-_130589349 | 6.13 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr1_-_130589321 | 6.11 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr2_-_28453374 | 6.11 |
ENSMUST00000028161.6
|
Cel
|
carboxyl ester lipase |
chr10_-_42354276 | 6.08 |
ENSMUST00000151747.8
|
Afg1l
|
AFG1 like ATPase |
chr14_+_79086492 | 6.02 |
ENSMUST00000040990.7
|
Vwa8
|
von Willebrand factor A domain containing 8 |
chr11_-_53313950 | 5.97 |
ENSMUST00000036045.6
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr17_-_74257164 | 5.95 |
ENSMUST00000024866.6
|
Xdh
|
xanthine dehydrogenase |
chr4_+_128887017 | 5.94 |
ENSMUST00000030583.13
ENSMUST00000102604.11 |
Ak2
|
adenylate kinase 2 |
chr2_+_126398048 | 5.93 |
ENSMUST00000141482.3
|
Slc27a2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr1_+_166081664 | 5.87 |
ENSMUST00000111416.7
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr19_+_3372296 | 5.84 |
ENSMUST00000237938.2
|
Cpt1a
|
carnitine palmitoyltransferase 1a, liver |
chr2_-_157408239 | 5.80 |
ENSMUST00000109528.9
ENSMUST00000088494.3 |
Blcap
|
bladder cancer associated protein |
chr7_+_140500848 | 5.69 |
ENSMUST00000184560.2
|
Nlrp6
|
NLR family, pyrin domain containing 6 |
chr6_+_91134358 | 5.68 |
ENSMUST00000155007.2
|
Hdac11
|
histone deacetylase 11 |
chr2_-_134396268 | 5.65 |
ENSMUST00000028704.3
|
Hao1
|
hydroxyacid oxidase 1, liver |
chr3_+_118355778 | 5.64 |
ENSMUST00000039177.12
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr3_-_79535966 | 5.64 |
ENSMUST00000120992.8
|
Etfdh
|
electron transferring flavoprotein, dehydrogenase |
chr2_-_25390625 | 5.56 |
ENSMUST00000040042.11
|
C8g
|
complement component 8, gamma polypeptide |
chr10_+_79552421 | 5.56 |
ENSMUST00000099513.8
ENSMUST00000020581.3 |
Hcn2
|
hyperpolarization-activated, cyclic nucleotide-gated K+ 2 |
chr8_-_13544478 | 5.41 |
ENSMUST00000033828.7
|
Gas6
|
growth arrest specific 6 |
chr14_+_75479727 | 5.37 |
ENSMUST00000022576.10
|
Cpb2
|
carboxypeptidase B2 (plasma) |
chr2_-_136733282 | 5.35 |
ENSMUST00000028730.13
ENSMUST00000110089.9 ENSMUST00000227806.2 |
Mkks
ENSMUSG00000115423.3
|
McKusick-Kaufman syndrome novel protein |
chr1_+_131725119 | 5.34 |
ENSMUST00000112393.9
ENSMUST00000048660.12 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr14_+_55813074 | 5.22 |
ENSMUST00000022826.7
|
Fitm1
|
fat storage-inducing transmembrane protein 1 |
chr10_-_42354482 | 5.21 |
ENSMUST00000041024.15
|
Afg1l
|
AFG1 like ATPase |
chr11_-_11848107 | 5.20 |
ENSMUST00000178704.8
|
Ddc
|
dopa decarboxylase |
chr17_-_26087696 | 5.16 |
ENSMUST00000236479.2
ENSMUST00000235806.2 ENSMUST00000026828.7 |
Mcrip2
|
MAPK regulated corepressor interacting protein 2 |
chr4_-_129121676 | 4.99 |
ENSMUST00000106051.8
|
C77080
|
expressed sequence C77080 |
chr2_-_69172944 | 4.98 |
ENSMUST00000102709.8
ENSMUST00000102710.10 ENSMUST00000180142.2 |
Abcb11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
chr7_+_44114815 | 4.86 |
ENSMUST00000035929.11
ENSMUST00000146128.8 |
Aspdh
|
aspartate dehydrogenase domain containing |
chr8_+_121395047 | 4.84 |
ENSMUST00000181795.2
|
Cox4i1
|
cytochrome c oxidase subunit 4I1 |
chr1_+_4878046 | 4.81 |
ENSMUST00000027036.11
ENSMUST00000150971.8 ENSMUST00000119612.9 ENSMUST00000137887.8 ENSMUST00000115529.8 |
Lypla1
|
lysophospholipase 1 |
chr9_-_21913833 | 4.78 |
ENSMUST00000115336.10
|
Odad3
|
outer dynein arm docking complex subunit 3 |
chr5_-_147259245 | 4.78 |
ENSMUST00000100433.5
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
chr11_-_11848044 | 4.77 |
ENSMUST00000066237.10
|
Ddc
|
dopa decarboxylase |
chr9_-_70048766 | 4.74 |
ENSMUST00000034749.16
|
Fam81a
|
family with sequence similarity 81, member A |
chr1_+_67162176 | 4.72 |
ENSMUST00000027144.8
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr6_+_91133647 | 4.72 |
ENSMUST00000041736.11
|
Hdac11
|
histone deacetylase 11 |
chr12_+_41074328 | 4.71 |
ENSMUST00000134965.8
|
Immp2l
|
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
chr2_+_92205651 | 4.71 |
ENSMUST00000028650.9
|
Pex16
|
peroxisomal biogenesis factor 16 |
chr18_+_45402018 | 4.68 |
ENSMUST00000183850.8
ENSMUST00000066890.14 |
Kcnn2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr1_+_139429430 | 4.63 |
ENSMUST00000027615.7
|
F13b
|
coagulation factor XIII, beta subunit |
chr7_+_44114857 | 4.63 |
ENSMUST00000135624.2
|
Aspdh
|
aspartate dehydrogenase domain containing |
chr5_-_108822619 | 4.61 |
ENSMUST00000119270.2
ENSMUST00000163328.8 ENSMUST00000136227.2 |
Slc26a1
|
solute carrier family 26 (sulfate transporter), member 1 |
chr10_+_110756031 | 4.60 |
ENSMUST00000220409.2
ENSMUST00000219502.2 |
Csrp2
|
cysteine and glycine-rich protein 2 |
chr8_-_85500010 | 4.60 |
ENSMUST00000109764.8
|
Nfix
|
nuclear factor I/X |
chr16_-_56984137 | 4.57 |
ENSMUST00000231733.2
|
Nit2
|
nitrilase family, member 2 |
chr14_-_20844034 | 4.55 |
ENSMUST00000226630.2
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma |
chr7_+_127399776 | 4.52 |
ENSMUST00000046863.12
ENSMUST00000206674.2 ENSMUST00000106272.8 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr17_+_15163466 | 4.51 |
ENSMUST00000164837.3
ENSMUST00000174004.2 |
1600012H06Rik
|
RIKEN cDNA 1600012H06 gene |
chr19_+_37686240 | 4.50 |
ENSMUST00000025946.7
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1 |
chr16_-_20549294 | 4.50 |
ENSMUST00000231826.2
ENSMUST00000076422.13 ENSMUST00000232217.2 |
Thpo
|
thrombopoietin |
chr1_-_164285914 | 4.49 |
ENSMUST00000027863.13
|
Atp1b1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr11_-_46581135 | 4.36 |
ENSMUST00000169584.8
|
Timd2
|
T cell immunoglobulin and mucin domain containing 2 |
chr7_-_126944754 | 4.33 |
ENSMUST00000205266.2
|
Zfp768
|
zinc finger protein 768 |
chr4_-_141351110 | 4.33 |
ENSMUST00000038661.8
|
Slc25a34
|
solute carrier family 25, member 34 |
chr3_+_122688721 | 4.33 |
ENSMUST00000023820.6
|
Fabp2
|
fatty acid binding protein 2, intestinal |
chr14_-_47426863 | 4.30 |
ENSMUST00000089959.7
|
Gch1
|
GTP cyclohydrolase 1 |
chr13_+_51254852 | 4.30 |
ENSMUST00000095797.6
|
Spin1
|
spindlin 1 |
chr6_-_124519240 | 4.28 |
ENSMUST00000159463.8
ENSMUST00000162844.2 ENSMUST00000160505.8 ENSMUST00000162443.8 |
C1s1
|
complement component 1, s subcomponent 1 |
chr7_+_127399789 | 4.24 |
ENSMUST00000125188.8
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr4_+_115420817 | 4.22 |
ENSMUST00000141033.8
ENSMUST00000030486.15 |
Cyp4a31
|
cytochrome P450, family 4, subfamily a, polypeptide 31 |
chr4_+_155646807 | 4.22 |
ENSMUST00000030939.14
|
Nadk
|
NAD kinase |
chr9_-_70842090 | 4.21 |
ENSMUST00000034731.10
|
Lipc
|
lipase, hepatic |
chr8_+_120121612 | 4.18 |
ENSMUST00000098367.5
|
Mlycd
|
malonyl-CoA decarboxylase |
chr15_+_76227695 | 4.17 |
ENSMUST00000023210.8
ENSMUST00000231045.2 |
Cyc1
|
cytochrome c-1 |
chr9_-_21913896 | 4.16 |
ENSMUST00000044926.6
|
Odad3
|
outer dynein arm docking complex subunit 3 |
chr4_+_115420876 | 4.15 |
ENSMUST00000126645.8
ENSMUST00000030480.4 |
Cyp4a31
|
cytochrome P450, family 4, subfamily a, polypeptide 31 |
chr6_+_41279199 | 4.13 |
ENSMUST00000031913.5
|
Try4
|
trypsin 4 |
chr5_-_25200745 | 4.12 |
ENSMUST00000076306.12
|
Prkag2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr9_-_21996693 | 4.09 |
ENSMUST00000179422.8
ENSMUST00000098937.10 ENSMUST00000177967.2 ENSMUST00000180180.8 |
Ecsit
|
ECSIT signalling integrator |
chr17_-_32639936 | 4.08 |
ENSMUST00000170392.9
ENSMUST00000237165.2 ENSMUST00000235892.2 ENSMUST00000114455.3 |
Pglyrp2
|
peptidoglycan recognition protein 2 |
chr11_+_75358866 | 4.08 |
ENSMUST00000043598.14
ENSMUST00000108435.2 |
Tlcd2
|
TLC domain containing 2 |
chr4_+_134124691 | 4.06 |
ENSMUST00000105870.8
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr6_+_91133755 | 4.04 |
ENSMUST00000143621.8
|
Hdac11
|
histone deacetylase 11 |
chr4_+_141473983 | 4.00 |
ENSMUST00000038161.5
|
Agmat
|
agmatine ureohydrolase (agmatinase) |
chr7_+_45546365 | 3.98 |
ENSMUST00000069772.16
ENSMUST00000210503.2 ENSMUST00000209350.2 |
Tmem143
|
transmembrane protein 143 |
chr7_+_83281193 | 3.96 |
ENSMUST00000117410.2
|
Stard5
|
StAR-related lipid transfer (START) domain containing 5 |
chr19_+_43770619 | 3.92 |
ENSMUST00000026208.6
|
Abcc2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
chr8_-_122379631 | 3.90 |
ENSMUST00000046386.5
|
Zcchc14
|
zinc finger, CCHC domain containing 14 |
chr9_+_21914083 | 3.86 |
ENSMUST00000216344.2
|
Prkcsh
|
protein kinase C substrate 80K-H |
chr9_+_107217786 | 3.82 |
ENSMUST00000042581.4
|
6430571L13Rik
|
RIKEN cDNA 6430571L13 gene |
chr16_+_23338960 | 3.78 |
ENSMUST00000211460.2
ENSMUST00000210658.2 ENSMUST00000209198.2 ENSMUST00000210371.2 ENSMUST00000211499.2 ENSMUST00000210795.2 ENSMUST00000209422.2 |
Gm45338
Rtp4
|
predicted gene 45338 receptor transporter protein 4 |
chr1_-_134163102 | 3.78 |
ENSMUST00000187631.2
ENSMUST00000038191.8 ENSMUST00000086465.6 |
Adora1
|
adenosine A1 receptor |
chr19_-_4548602 | 3.76 |
ENSMUST00000048482.8
|
2010003K11Rik
|
RIKEN cDNA 2010003K11 gene |
chr5_+_115604321 | 3.70 |
ENSMUST00000145785.8
ENSMUST00000031495.11 ENSMUST00000112071.8 ENSMUST00000125568.2 |
Pla2g1b
|
phospholipase A2, group IB, pancreas |
chr16_+_17149235 | 3.63 |
ENSMUST00000023450.15
ENSMUST00000231884.2 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr17_+_85335775 | 3.63 |
ENSMUST00000024944.9
|
Slc3a1
|
solute carrier family 3, member 1 |
chr18_-_62044871 | 3.62 |
ENSMUST00000166783.3
ENSMUST00000049378.15 |
Ablim3
|
actin binding LIM protein family, member 3 |
chr16_+_10363222 | 3.61 |
ENSMUST00000155633.8
ENSMUST00000066345.15 |
Clec16a
|
C-type lectin domain family 16, member A |
chr19_-_39451509 | 3.61 |
ENSMUST00000035488.3
|
Cyp2c38
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
chr15_+_25843225 | 3.61 |
ENSMUST00000022881.15
|
Retreg1
|
reticulophagy regulator 1 |
chr11_+_100973391 | 3.60 |
ENSMUST00000001806.10
ENSMUST00000107308.4 |
Coasy
|
Coenzyme A synthase |
chr11_-_113600346 | 3.58 |
ENSMUST00000173655.8
ENSMUST00000100248.6 |
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr7_-_126496534 | 3.58 |
ENSMUST00000120007.8
|
Tmem219
|
transmembrane protein 219 |
chr7_-_79492091 | 3.58 |
ENSMUST00000049004.8
|
Anpep
|
alanyl (membrane) aminopeptidase |
chr4_-_115932219 | 3.56 |
ENSMUST00000050580.11
ENSMUST00000078676.6 |
Uqcrh
|
ubiquinol-cytochrome c reductase hinge protein |
chr2_-_26494277 | 3.56 |
ENSMUST00000028286.12
|
Agpat2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) |
chr1_-_120001752 | 3.55 |
ENSMUST00000056089.8
|
Tmem37
|
transmembrane protein 37 |
chr3_+_122298308 | 3.53 |
ENSMUST00000199358.2
|
Bcar3
|
breast cancer anti-estrogen resistance 3 |
chr4_+_138694422 | 3.51 |
ENSMUST00000116094.5
ENSMUST00000239443.2 |
Rnf186
|
ring finger protein 186 |
chr13_-_64514830 | 3.48 |
ENSMUST00000222971.2
|
Ctsl
|
cathepsin L |
chr17_-_34247016 | 3.45 |
ENSMUST00000236627.2
ENSMUST00000237759.2 ENSMUST00000045467.14 ENSMUST00000114303.4 |
H2-Ke6
|
H2-K region expressed gene 6 |
chr3_+_62245765 | 3.45 |
ENSMUST00000079300.13
|
Arhgef26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr6_-_119444157 | 3.44 |
ENSMUST00000118120.8
|
Wnt5b
|
wingless-type MMTV integration site family, member 5B |
chr1_+_167445815 | 3.44 |
ENSMUST00000111380.2
|
Rxrg
|
retinoid X receptor gamma |
chr9_-_110571645 | 3.41 |
ENSMUST00000006005.12
|
Pth1r
|
parathyroid hormone 1 receptor |
chr2_-_160714749 | 3.39 |
ENSMUST00000176141.8
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr6_-_119521243 | 3.38 |
ENSMUST00000119369.2
ENSMUST00000178696.8 |
Wnt5b
|
wingless-type MMTV integration site family, member 5B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.7 | 103.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
9.9 | 39.7 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
6.8 | 34.2 | GO:1904970 | brush border assembly(GO:1904970) |
5.9 | 17.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
5.9 | 17.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
5.0 | 29.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
4.7 | 14.1 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
4.1 | 12.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
3.9 | 3.9 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
3.8 | 19.1 | GO:0035359 | negative regulation of triglyceride catabolic process(GO:0010897) negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
3.6 | 10.7 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
3.5 | 24.3 | GO:0060335 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) heme transport(GO:0015886) positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
3.4 | 37.2 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
3.4 | 10.1 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
3.4 | 10.1 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
3.3 | 19.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
3.2 | 9.7 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
3.1 | 9.2 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
3.0 | 8.9 | GO:0019860 | uracil catabolic process(GO:0006212) uracil metabolic process(GO:0019860) |
2.9 | 22.9 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
2.8 | 8.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
2.5 | 12.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
2.4 | 4.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.3 | 9.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.2 | 8.8 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.1 | 10.7 | GO:0034371 | chylomicron remodeling(GO:0034371) |
2.1 | 6.3 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
2.0 | 5.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.9 | 11.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.8 | 5.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.8 | 7.2 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
1.8 | 5.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.7 | 8.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
1.6 | 8.0 | GO:0051715 | cytolysis in other organism(GO:0051715) |
1.6 | 9.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.6 | 14.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
1.6 | 4.7 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
1.5 | 1.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.5 | 7.5 | GO:0009441 | glycolate metabolic process(GO:0009441) |
1.5 | 23.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.4 | 10.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
1.4 | 4.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.4 | 5.4 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.3 | 5.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.3 | 7.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.3 | 3.8 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
1.2 | 18.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.2 | 4.9 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
1.2 | 6.0 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
1.2 | 7.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.2 | 7.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.1 | 10.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.1 | 4.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.1 | 14.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.1 | 4.3 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
1.0 | 32.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.0 | 6.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
1.0 | 12.2 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
1.0 | 4.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.0 | 2.9 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
1.0 | 9.6 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.9 | 6.3 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.8 | 2.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.8 | 0.8 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) positive regulation of hindgut contraction(GO:0060450) |
0.8 | 11.3 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.8 | 5.6 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.8 | 4.8 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.8 | 5.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.8 | 4.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.8 | 4.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.8 | 10.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.7 | 14.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.7 | 0.7 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.7 | 12.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.7 | 8.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.7 | 5.0 | GO:0046618 | drug export(GO:0046618) |
0.7 | 2.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 11.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.7 | 1.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.7 | 8.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 5.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.6 | 2.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.6 | 6.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 4.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 7.7 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 3.2 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.6 | 2.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.6 | 1.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.6 | 3.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.6 | 10.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 1.7 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.6 | 1.7 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
0.6 | 2.3 | GO:0015744 | succinate transport(GO:0015744) |
0.6 | 1.7 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.5 | 3.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.5 | 4.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.5 | 5.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 2.6 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
0.5 | 4.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 4.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.5 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 2.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.5 | 2.9 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.5 | 1.9 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.5 | 1.4 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.4 | 5.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 2.2 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) |
0.4 | 5.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 2.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 2.1 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
0.4 | 3.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 20.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 2.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.4 | 2.9 | GO:1902861 | cellular response to cisplatin(GO:0072719) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.4 | 10.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 2.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.4 | 1.2 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
0.4 | 1.2 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
0.4 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 1.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.4 | 1.2 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.4 | 3.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 3.4 | GO:0061709 | reticulophagy(GO:0061709) |
0.4 | 3.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 2.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.4 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 4.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 1.4 | GO:0021917 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.3 | 1.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 1.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 5.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 1.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.3 | 1.0 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 2.6 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.3 | 2.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.3 | 6.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.3 | 0.3 | GO:0003130 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.3 | 0.6 | GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
0.3 | 1.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.3 | 3.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 0.9 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
0.3 | 4.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 3.5 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 7.6 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 2.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.3 | 2.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 1.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.3 | 6.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 2.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 14.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.3 | 0.5 | GO:0009644 | response to high light intensity(GO:0009644) |
0.3 | 2.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.3 | 3.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 2.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.7 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 2.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.2 | 1.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 1.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 2.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 8.2 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.2 | 0.9 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.2 | 0.9 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.2 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.2 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.2 | 1.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.6 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.2 | 2.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 | 3.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 1.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 3.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 3.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 1.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 1.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 16.8 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.2 | 3.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.9 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 3.9 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.4 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.2 | 2.4 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 1.1 | GO:0061525 | hindgut development(GO:0061525) |
0.2 | 3.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 1.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 2.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 3.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 1.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.2 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 4.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 1.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 1.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 5.8 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.2 | 3.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.2 | 7.8 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 1.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.5 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.2 | 9.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 5.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 1.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.6 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) positive regulation of glial cell migration(GO:1903977) |
0.2 | 1.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 4.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 1.2 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 2.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.1 | 6.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 2.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 2.5 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 5.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 4.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 6.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 1.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.5 | GO:0016062 | response to light intensity(GO:0009642) adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 2.2 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 14.9 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 1.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.4 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 3.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 3.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 2.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 2.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 1.0 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 0.5 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 0.5 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.9 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.9 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.6 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
0.1 | 1.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) maintenance of mitochondrion location(GO:0051659) |
0.1 | 6.5 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 14.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 3.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 1.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 8.5 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.4 | GO:0070781 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.1 | 1.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 2.0 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.6 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 1.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 2.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.2 | GO:0045763 | negative regulation of cellular amine metabolic process(GO:0033239) negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 3.0 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.4 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 1.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 2.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 2.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 4.8 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 1.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.4 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 3.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 3.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 1.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.8 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 3.0 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 4.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.7 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 2.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 1.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 12.2 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 2.8 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.1 | 1.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 3.1 | GO:0001707 | mesoderm formation(GO:0001707) |
0.1 | 1.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 5.2 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 1.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 1.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 7.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 11.2 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 1.4 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 1.2 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 1.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 2.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 2.4 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 1.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 1.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 1.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.4 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 3.9 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.8 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 1.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 3.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.5 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 1.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.4 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 5.6 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 1.5 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.6 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.8 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 2.8 | GO:0030324 | lung development(GO:0030324) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.4 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 2.3 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.0 | 0.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.3 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.8 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:2000727 | positive regulation of cardiocyte differentiation(GO:1905209) positive regulation of cardiac muscle cell differentiation(GO:2000727) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.4 | 103.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
4.9 | 19.5 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
3.5 | 35.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
3.4 | 10.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
2.5 | 12.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.3 | 9.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
2.3 | 9.2 | GO:0097636 | platelet dense granule membrane(GO:0031088) intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
1.9 | 5.6 | GO:0098855 | HCN channel complex(GO:0098855) |
1.8 | 9.1 | GO:0017177 | glucosidase II complex(GO:0017177) |
1.8 | 5.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
1.6 | 4.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
1.5 | 16.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.5 | 17.4 | GO:0042627 | chylomicron(GO:0042627) |
1.3 | 14.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
1.0 | 5.9 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
1.0 | 9.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.9 | 2.6 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.8 | 3.3 | GO:0032280 | axonemal microtubule(GO:0005879) symmetric synapse(GO:0032280) |
0.7 | 3.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.7 | 2.1 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.7 | 6.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.7 | 4.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.7 | 18.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 3.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 11.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.6 | 5.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 7.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.6 | 7.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 11.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.5 | 5.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 8.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 34.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 3.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 3.0 | GO:0097444 | spine apparatus(GO:0097444) |
0.4 | 1.2 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.4 | 4.3 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 18.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 1.4 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.4 | 2.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.4 | 10.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 23.8 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 3.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 1.0 | GO:0043291 | RAVE complex(GO:0043291) |
0.3 | 3.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 1.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 7.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 8.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 1.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.3 | 1.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 5.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 3.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 7.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 37.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 66.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 2.2 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 8.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 3.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.9 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 21.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 4.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 11.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 1.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 2.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 6.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.8 | GO:0032444 | activin responsive factor complex(GO:0032444) SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 0.8 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.6 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 0.9 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 3.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 1.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 11.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 4.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.8 | GO:0097433 | dense body(GO:0097433) |
0.1 | 19.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 23.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 37.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 1.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 7.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 9.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 3.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 3.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.8 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 5.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 2.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 10.2 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 6.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.0 | 6.7 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.1 | GO:0071914 | prominosome(GO:0071914) |
0.0 | 58.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 4.9 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.7 | 103.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
7.8 | 23.4 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
6.5 | 19.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
5.8 | 40.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
5.8 | 23.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
5.0 | 29.9 | GO:0004359 | glutaminase activity(GO:0004359) |
5.0 | 14.9 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
4.9 | 14.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
4.7 | 14.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
4.4 | 17.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
4.1 | 16.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
4.1 | 24.3 | GO:0015232 | heme transporter activity(GO:0015232) |
3.4 | 10.3 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) quercetin 2,3-dioxygenase activity(GO:0008127) |
3.3 | 10.0 | GO:0005009 | insulin-activated receptor activity(GO:0005009) |
3.2 | 9.7 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
3.2 | 19.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
3.0 | 8.9 | GO:0002061 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
2.9 | 17.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.8 | 8.5 | GO:0070279 | vitamin B6 binding(GO:0070279) |
2.8 | 19.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.5 | 10.0 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
2.4 | 12.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
2.2 | 8.8 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
2.1 | 10.7 | GO:0035478 | chylomicron binding(GO:0035478) |
2.1 | 19.1 | GO:0035473 | lipase binding(GO:0035473) |
2.1 | 6.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
2.0 | 6.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.9 | 5.8 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
1.6 | 4.7 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
1.4 | 5.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.4 | 12.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.3 | 6.7 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
1.3 | 6.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.3 | 6.3 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
1.3 | 8.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.2 | 10.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.2 | 3.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.2 | 6.0 | GO:0030151 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) molybdenum ion binding(GO:0030151) molybdopterin cofactor binding(GO:0043546) |
1.1 | 6.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.1 | 15.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.1 | 8.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.0 | 3.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.0 | 4.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
1.0 | 11.3 | GO:0032052 | bile acid binding(GO:0032052) |
1.0 | 5.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.0 | 2.0 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.9 | 5.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.9 | 4.4 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.8 | 2.5 | GO:0038052 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.8 | 7.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 3.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.8 | 2.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.8 | 3.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.8 | 4.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.7 | 2.2 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.7 | 7.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 3.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 4.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.7 | 4.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.7 | 4.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.6 | 7.7 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 6.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 3.6 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.6 | 1.7 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.6 | 10.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.6 | 1.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.5 | 2.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 3.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 1.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.5 | 7.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 4.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.5 | 3.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 18.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.5 | 1.5 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.5 | 14.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 20.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.5 | 0.5 | GO:0086062 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.5 | 3.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.5 | 1.4 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.5 | 11.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 1.8 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.5 | 1.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 0.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 1.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 2.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 2.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.4 | 1.7 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.4 | 1.3 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
0.4 | 3.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 2.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 3.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 11.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.4 | 3.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 9.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 33.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 1.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 1.2 | GO:0034012 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
0.4 | 7.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 6.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 1.5 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.4 | 2.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 4.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 2.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.4 | 0.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 1.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 3.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 1.7 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 5.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 7.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.3 | 1.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 2.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 5.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 2.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 6.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 1.8 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 0.9 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.3 | 9.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 1.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 9.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 12.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 2.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.3 | 0.8 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.3 | 3.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 1.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 7.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 38.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 1.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.3 | 4.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 2.5 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 2.7 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 8.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 10.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 3.9 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 2.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.6 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) |
0.2 | 43.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 6.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 2.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 2.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 9.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 8.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 2.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 4.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 14.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.2 | 6.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 2.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 10.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 2.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 5.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 4.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 1.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 3.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 4.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 2.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 2.6 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 2.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 3.0 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 1.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 1.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.6 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 2.8 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0018271 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 1.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 2.7 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 3.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 8.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 2.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 2.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 0.9 | GO:0102391 | long-chain fatty acid-CoA ligase activity(GO:0004467) decanoate--CoA ligase activity(GO:0102391) |
0.1 | 2.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 7.9 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 4.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 2.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 1.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 3.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 7.7 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 8.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 2.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 4.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 2.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 4.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.1 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 2.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 2.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 1.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 1.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 2.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 1.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.0 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 1.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.9 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 2.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 2.2 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 4.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 1.3 | GO:0016298 | lipase activity(GO:0016298) |
0.0 | 0.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 1.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.6 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 3.2 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 24.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 7.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 7.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 15.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 14.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 8.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 20.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 6.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 9.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 4.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 3.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 4.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 2.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 12.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 3.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 2.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 1.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 96.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
2.0 | 27.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.8 | 51.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.6 | 33.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.5 | 20.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.5 | 23.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.4 | 18.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.4 | 27.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.4 | 28.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.1 | 17.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.1 | 12.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 19.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.0 | 75.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.9 | 10.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.9 | 10.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.7 | 5.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 11.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.6 | 5.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.6 | 6.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 6.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 18.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 7.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 9.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 8.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 8.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 0.8 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.4 | 13.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 28.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 22.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 2.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 4.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 2.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 4.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 2.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 6.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 0.9 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 3.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 6.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 18.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 5.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 3.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 4.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 4.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 4.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 12.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 12.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 10.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 23.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 3.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 10.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 7.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 6.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 2.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 2.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 1.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 1.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 1.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.3 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |